Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_assertion type Assertion NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_head.
- NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_assertion wasGeneratedBy ECO_0000203 NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_provenance.
- NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_assertion wasDerivedFrom befree-20140225 NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_provenance.
- NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_assertion SIO_000772 19553641 NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_provenance.
- NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_assertion evidence source_evidence_literature NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_provenance.
- NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_assertion description "[Olaparib has few of the adverse effects of conventional chemotherapy, inhibits PARP, and has antitumor activity in cancer associated with the BRCA1 or BRCA2 mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270813.RAMQzaMCbgGPYrJyJGDbp9msyv-35thQoTpfAyUKZKeSM130_provenance.